Evidence map›Paper›PMID 32015508›Full record

ArticleNature2020

A new coronavirus associated with human respiratory disease in China.

Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei and 9 more

Erratum issued 11 registry-linked trialsOpen access · hybridAbstract readCase Reports
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 11 registered trials, which are not on this map. Cited by 6,147 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6,147citing papers in PubMed, 4 pooled it
292.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04324996 phase1 / phase2unknown statusnot on this map

A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells Secreting IL15 Superagonist and GM-CSF-neutralizing scFv for Therapy of COVID-19

TypeinterventionalSponsorChongqing Public Health Medical CenterRan2020 to 2022Enrolled90ConditionsCOVID-19ArmsNK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells
NCT04432103 phase3terminatednot on this map

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

TypeinterventionalSponsorCentro Medico ABCRan2020 to 2021Enrolled6ConditionsCovid-19ArmsAnti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients, Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients
NCT04548557 phase3unknown statusnot on this map

Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial

TypeinterventionalSponsorUniversity of Health Sciences LahoreRan2020 to 2020Enrolled60ConditionsCovid19Armsintravenous immunoglobulin therapy
NCT04766645 completednot on this map

Gender Differences in Stroke With COVID-19: Epigenetic and Biochemical Study of ACE2 Receptor and Relationship With Rehabilitative Outcome

TypeobservationalSponsorFondazione Don Carlo Gnocchi ETSRan2020 to 2023Enrolled77ConditionsNeurologic ManifestationsArmsRobotic assisted intervention, epigenetic analyses, biochemical analyses
NCT05175716 completednot on this mapstarted 2022, after this paper: background citation

Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth Room

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2022 to 2022Enrolled2,447ConditionsCOVID-19, Labor
NCT05205746 phase2completednot on this mapstarted 2021, after this paper: background citation

Phase II Study to Evaluate Immunogenicity and Safety in Subjects With Evidence of Prior Immunity to SARS-CoV-2 of a Single Intramuscular or Intranasal Dose of the Live Recombinant Newcastle Disease Virus Based AVX/COVID-12 Vaccine

TypeinterventionalSponsorLaboratorio Avi-Mex, S.A. de C.V.Ran2021 to 2023Enrolled158ConditionsSARS CoV 2 InfectionArmsRecombinant NDV Vectored Vaccine for SARS-CoV-2, Placebo
NCT05507671 phase3active not recruitingnot on this mapstarted 2021, after this paper: background citation

The Role of the Bacillus Calmette-Guérin Vaccine (BCG) in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) Vaccines

TypeinterventionalSponsorOswaldo Cruz FoundationRan2021 to 2025Enrolled556ConditionsCOVID-19ArmsBCG (Bacillus Calmette-Guérin) vaccine, Placebo
NCT05710783 phase2 / phase3completednot on this mapstarted 2022, after this paper: background citation

Phase II/III Parallel, Double-blind, Non-inferiority Study With Active Control, to Evaluate the Immunogenicity and Safety of a Booster Immunization Scheme With a Single Intramuscular Dose of the Recombinant Vaccine Against SARS-CoV-2

TypeinterventionalSponsorLaboratorio Avi-Mex, S.A. de C.V.Ran2022 to 2023Enrolled4,065ConditionsSARS-CoV-2 InfectionArmsAVX-COVID/12, ChAdOx-1-S[recombinant]
NCT06027398 nacompletednot on this mapstarted 2021, after this paper: background citation

Efficacy of SARS-COV-2 Detection From Used Surgical Mask Compared to Standard Detection Method

TypeinterventionalSponsorBangkok Metropolitan Administration Medical College and Vajira HospitalRan2021 to 2021Enrolled269ConditionsSARS-CoV-2 VirusArmsSARS-CoV-2 RNA detection
NCT06566898 recruitingnot on this mapstarted 2024, after this paper: background citation

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients: a Genomic Epidemiology Study

TypeobservationalSponsorShanghai General Hospital, ChinaRan2024 to 2026Enrolled800ConditionsPneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
NCT06775808 recruitingnot on this mapstarted 2024, after this paper: background citation

Total Infectome Characterization of Eye Infections: a Metagenomic Sequencing Based Observational Study

TypeobservationalSponsorShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRan2024 to 2026Enrolled200ConditionsEye Infections, Diagnosis
3 · Its place in the literature

Who cites it

6,147 citing papers in PubMed, 4 syntheses or guidelines pooled it, 12,814 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

6,087 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Fan Wu *Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Su Zhao *Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Bin Yu *Wuhan Center for Disease Control and Prevention, Wuhan, China.
Yan-Mei Chen *Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wen Wang *Department of Zoonosis, National Institute for Communicable Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China.
Zhi-Gang Song *Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yi Hu *Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.ORCID http://orcid.org/0000-0002-2882-5210
Zhao-Wu TaoDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun-Hua TianWuhan Center for Disease Control and Prevention, Wuhan, China.
Yuan-Yuan PeiShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Ming-Li YuanDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yu-Ling ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Fa-Hui DaiShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yi LiuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Qi-Min WangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jiao-Jiao ZhengShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Lin XuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Edward C HolmesShanghai Public Health Clinical Center, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-9596-3552
Yong-Zhen ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China. zhangyongzhen@shphc.org.cn.
Shanghai Public Health Clinical Center · CNCentral Hospital of Wuhan · CNWuhan Center for Disease Control and Prevention · CNNational Institute for Communicable Disease Control and Prevention · CNThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health

Indexed as

AdultBetacoronavirusChinaCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19Genome, ViralHumansLungMalePhylogenyPneumonia, ViralRecombination, GeneticRNA, ViralSARS-CoV-2Severe Acute Respiratory SyndromeRNA, Viral

Identifiers

PMID32015508
PMCPMC7094943
OpenAlexW3003217347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 5 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.